What the FDA labels say about taking them together
Atezolizumab and lurbinectedin
Lurbinectedin's FDA label of February 27, 2026 names atezolizumab in its warnings and precautions section; the atezolizumab label PlainMeds reads does not name lurbinectedin. The lurbinectedin label: “To reduce the risk of febrile neutropenia during treatment with ZEPZELCA in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs, administer granulocyte colony-stimulating factor (G-CSF) [refer to …”
Check it at the source: the atezolizumab FDA label on DailyMed (effective May 20, 2026, Genentech, Inc.); the lurbinectedin FDA label on DailyMed (effective February 27, 2026, Jazz Pharmaceuticals, Inc.).
What does the atezolizumab label say about lurbinectedin?
Atezolizumab's label (effective May 20, 2026) does not name lurbinectedin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (TECENTRIQ), Genentech, Inc., effective May 20, 2026 (SPL set 6fa682c9-a312-4932-9831-f286908660ee), via openFDA; the full label on DailyMed
What does the lurbinectedin label say about atezolizumab?
Lurbinectedin label, warnings and precautionsTo reduce the risk of febrile neutropenia during treatment with ZEPZELCA in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs, administer granulocyte colony-stimulating factor (G-CSF) [refer to Prescribing Information].
Source: FDA drug label (ZEPZELCA), Jazz Pharmaceuticals, Inc., effective February 27, 2026 (SPL set 632bb50c-3bcb-4c85-9056-fc33410550ae), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Atezolizumab | Lurbinectedin | |
|---|---|---|
| Labeled for | Lung cancer | Lung cancer |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once